about
Dynamic self-guiding analysis of Alzheimer's disease.Neuroprotective Sirtuin ratio reversed by ApoE4High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice.Reversal of cognitive decline: a novel therapeutic programDirect Transcriptional Effects of Apolipoprotein ETargeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational BiomarkerExploring the association between interleukin-1β and its interacting proteins in Alzheimer's disease.Reversal of cognitive decline in Alzheimer's disease.
P2860
Q28080897-543ED9CE-21C4-4C45-A603-C66E681EBCACQ28300666-659A5025-A3E4-4236-AFE6-555701160CEDQ30586174-A025D805-9E05-4ED1-A3FE-F677D9C881A5Q34461143-2B362E06-45E0-45BC-A9A7-ED9E98B71A1AQ36480230-E76A9EC4-FA2C-4BF2-A47A-ED7E8ECF7295Q37258840-78ABC95A-C7D7-4512-9F30-E84A53F64F3BQ41546658-69DD6E56-9EAD-4DF4-9CEB-24AEEEB6D993Q42433808-BEF2EBED-5E3F-4D70-8620-7448AD913AE5
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Next generation therapeutics for Alzheimer's disease.
@en
Next generation therapeutics for Alzheimer's disease.
@nl
type
label
Next generation therapeutics for Alzheimer's disease.
@en
Next generation therapeutics for Alzheimer's disease.
@nl
prefLabel
Next generation therapeutics for Alzheimer's disease.
@en
Next generation therapeutics for Alzheimer's disease.
@nl
P2860
P356
P1476
Next generation therapeutics for Alzheimer's disease.
@en
P2093
Dale E Bredesen
Varghese John
P2860
P304
P356
10.1002/EMMM.201202307
P577
2013-05-23T00:00:00Z